$HIMS TRADE IDEANYSE:HIMS What do you think about this trade idea? This stock has respected this trendline for the past two years and has not broken below it even once during that time. That alone highlights how strong and reliable this level has been. Over the last 12 months, the stock has delivered an impressive run with solid growth, showing strong underlying momentum and sustained buyer interest.
Recently, price has pulled back toward this long-term trendline, giving what looks like a discounted entry compared to recent highs. From a risk-to-reward perspective, this area becomes especially interesting because the trendline provides a clear level to manage risk.
If this is one of your favorite stock, this is a level you should be paying close attention to over the next couple of weeks. As long as the price continues to respect this trendline, the structure remains intact and the setup stays attractive. A strong reaction from this level could lead to another leg higher, while a break would signal a change in trend worth reassessing.
HIMS-HERS
Hims & Hers Health (HIMS) AnalysisHims & Hers Health NYSE:HIMS is a leading telehealth platform delivering personalized care in sexual health, hair loss, dermatology, mental health, and weight loss.
Growth Drivers:
Weight Loss Service Momentum ⚡
Q1 2025 launch of a GLP-1 prescription program with coaching & diagnostics has unlocked a major new revenue stream.
Strong adoption is fueling accelerated growth.
Subscriber & Revenue Growth 📊
Q2 2025 subscribers surged 31–38% YoY to 2.4M.
Monthly revenue per subscriber jumped 30% to $74, reflecting deeper engagement.
Operational Leverage 🤖
AI-driven care and pharmacy automation are enhancing scalability and margins.
Partnership expansions are broadening reach and improving efficiency.
Investment Outlook:
Bullish Case: We remain bullish above $54.00–$55.00, supported by high-margin recurring revenue and strong subscriber momentum.
Upside Potential: Target: $110.00–$115.00, driven by continued adoption of GLP-1 programs, tech-enabled scalability, and strategic partnerships.
📢 HIMS—Scaling Digital Healthcare with AI, Innovation, and Strong Subscriber Economics. #HIMS #Telehealth #GLP1 #DigitalHealth #GrowthStocks
HIMS EARNINGS CHART, DO BULLS HAVE ANY UPSIDE REMAINING? Short answer, yep.
LOTS.
Longer answer, this is a key price zone.
Take a look back at the chart as a whole.
It almost looks like it wants to hit 12.5 tomorrow and GAP up earnings.
Hard to say for sure because it's not a stock I watch often.
BUT, it's flashing some bullish signals.
Good luck!


